Palmitic acid‐ and cysteine‐functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug
Abstract Nanoparticles (NPs) used for oral administration have greatly improved drug bioavailability and therapeutic efficacy. Nevertheless, NPs are limited by biological barriers, such as gastrointestinal degradation, mucus barrier, and epithelial barrier. To solve these problems, we developed the...
Main Authors: | Yinzhuo Xie, Zheng Jin, Da Ma, Tan Hui Yin, Kai Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Bioengineering & Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/btm2.10510 |
Similar Items
-
Yolk-shell cationic liposomes overcome mucus and epithelial barriers for enhanced oral drug delivery
by: Yu Qiu, et al.
Published: (2024-03-01) -
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
by: Deepak A. Subramanian, et al.
Published: (2022-08-01) -
Interactions between microbiota and cervical epithelial, immune, and mucus barrier
by: Mengting Dong, et al.
Published: (2023-02-01) -
Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin
by: Ahmed M. Omer, et al.
Published: (2021-01-01) -
Chondroitin sulfate functionalized palmitic acid and cysteine cografted-quaternized chitosan for CD44 and gut microbiota dual-targeted delivery of curcumin
by: Yinzhuo Xie, et al.
Published: (2023-06-01)